Select which cookies you accept
When you visit this website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the website work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience.
Because we respect your right to privacy, you can choose not to allow some types of cookies. Below is a list of different categories of cookies that may be set and that you can freely change. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.
These cookies are required and must be accepted to use this site.
These cookies collect data about how visitors use this website.
These cookies allow the website to remember choices you make and provide enhanced, more personal features.
These cookies are used to deliver adverts more relevant to you and your interests.
Accept these cookies
As a member of our united staff function you´ll work strategically to deliver business insight and support to a growing global company.
INNOVATION - We are curious and explore new ways. - We are also ambitious and find solutions.
EXCELLENCE - We have a strong technical knowledge, and we deliver results - We lead quality in everything we do - We are adaptable and customer focused TRUST - We believe in teamwork and collaboration. - We lead by example and accept responsibility - We are transparent and we show integrity.
PolyPeptide is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world.
PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six GMP-certified facilities in Europe, the U.S. and India with around 1,200 employees as per the middle of 2022. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.